The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHyundai Mtr.gdr Regulatory News (HYUD)

Share Price Information for Hyundai Mtr.gdr (HYUD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.40
Bid: 57.40
Ask: 57.80
Change: -0.40 (-0.69%)
Spread: 0.40 (0.697%)
Open: 57.60
High: 58.40
Low: 57.40
Prev. Close: 57.80
HYUD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convening Notice of AGM

22 Feb 2013 09:09

RNS Number : 4727Y
Hyundai Motor Company
22 February 2013
 



HYUNDAI MOTOR COMPANY (HMC)
Corporate Disclosure to Korea Exchange
 
 
Disclosure Date : February 21, 2013
Disclosure Title : Convening Notice for the Annual General Meeting of Shareholders for the 45th Fiscal Year
 
 
 
The Annual General Meeting of Shareholders of Hyundai Motor Company (the “Company”) will be held pursuant to Article 365 of the Korean Commercial Code and Article 14 of the Articles of Incorporation of the Company as follows.
 
 
1 Date : 9:00 a.m., March 15, 2013 (Friday)
 
2 Place: Grand Hall, 2nd Floor West Building, Head office of Hyundai Motor Company,
231, Yangjae-Dong, Seocho-Gu, Seoul, 137-938, Korea
(For any questions, please call +82-2-3464-1114)
 
3 Purposes of the Meeting
Annual Report, Independent Auditor’s Report
< Agenda >
Item 1: Approval of financial statements for the 45th business year (1/1/2012 ~ 12/31/2012)
Item 2: Appointment of director(s)
Item 3: Appointment of member(s) of Audit Committee
Item 4: Amendment to the Articles of Incorporation
Item 5: Approval of director’s compensation cap
 
4 Matters regarding the Exercise of Voting Rights:
< What to bring to the shareholders’ meeting >
- For the in-person exercise of the voting right of a shareholder: 
an invitation to the shareholders’ meeting of the company, and an identification
- For the exercise of the voting right of a shareholder by proxy: 
an invitation to the shareholders’ meeting of the company, a power of attorney ((1) with necessary information of the relevant shareholder and the person with the power of attorney filled in; and (2) duly executed and sealed), and an identification of the agent.
applicable only to a beneficial owner of the share(s) issued by the Company>
- If you are a beneficial owner of the share(s) which has/have been deposited with a stock brokerage firm, please refer to the next page.
 
 
5. Other matters
For the 45th fiscal year, the Company expects to pay a cash dividend of KRW 1,900 for per share of common stock. (Series 1 Preferred Stock: KRW 1,950; Series 2 Preferred Stock: KRW 2,000; Series 3 Preferred Stock: KRW 1,950)
 
 
 
 
 
 
February 21, 2013
 
HYUNDAI MOTOR COMPANY
Representative Director: Kim Choong Ho
(Seal omitted)
Guide on How to Exercise Voting Rights of Beneficial Owners
 
As you may know, a voting right is your right and an important method to reflect your opinion at the shareholders' meeting. However, under the circumstances where the shares issued by the company are held by numerous shareholders, it may be difficult to constitute a quorum at the shareholders' meeting. Therefore, please refer to the following on how to exercise your voting right as a beneficial owner (i.e., as a shareholder holding a share or shares of the company in an account with a stock brokerage firm), and your cooperation will be appreciated.
 
General Types of How to Exercise Voting Rights
A shareholder may be present at the shareholders' meeting and exercise his/her voting right at the shareholders' meeting.
A shareholder may have a third party exercise his/her voting right as his/her agent
 
Exercise of Voting Rights by the Korea Securities Depository
In accordance with Article 314 of the Capital Market and Financial Investment Business Act of Korea, the company will ask the Korea Securities Depository to, on any issues with respect to which no opinion is expressed in the Opinion Notice attached below, exercise voting rights on behalf of such beneficial owners of shares of the company in case of such beneficial owners do not express their opinion to the Korea Securities Depository by the Opinion Notice in the form attached below. In such case, the Korea Securities Depository may, pursuant to the Capital Market and Financial Investment Business Act of Korea, conduct shadow voting based on the ratio between the agreement and disagreement to each issue as a result of the exercise of voting rights by all shareholders present at the shareholders' meeting except those represented by the Korea Securities Depository.
 
Advice on Delivery of Opinion Notice
It would be appreciated if a beneficial owner of a share or shares of the company would execute and send the Opinion Notice attached below for the purpose of the Korea Securities Depository's computation of the number of shares available for its exercise of voting rights, which shares will not include any shares with respect to which shareholder's opinion is expressed in the Opinion Notice attached below.
 
Delivery of the Opinion Notice to the following address is not a must. There will be no disadvantage or impediment to the exercise of any of your rights as a shareholder of the company, even though you do not send the Opinion Notice to the following address:
‘Person in charge of Opinion Notice of Beneficial Owner of a share or shares of Company’ , Korea Securities Depository, 34-6 Yoido-Dong, Yeongdeungpo-Ku, 150-884, Seoul, Korea
Fax: (02) 3774-3244, 3774-3245
March 8, 2013 (5 business days before the date of the AGM)
----------------------------------------------------------------------------------------------------------------
 
 

 
 
Notice of Expression of Intention
 
To Korea Securities Depository
 
I, the undersigned, hereby, pursuant to Article 314 of the Capital Market and Financial Investment Business Act of Korea, declare my intention with respect to the exercise of voting rights on the shares owned by me at the annual general shareholders meeting of Hyundai Motor Company to be held on March 15, 2013 and any presumptive or continuous meeting thereto as follows:
 
 
 
 
Beneficial Shareholder No.
 
Expression of Intention
 
 
 
Resident Registration No.
 
In Person
By Proxy
Non-Exercise
 
 
 
Number of Voting Rights
 
 
 
 
 
 
 
 
 
 
[ ] days of [ ] month of year 2013
 
Beneficial Shareholder Name : (Seal)
Address :
 
 
 

1. Agenda of the Annual General Meeting of Shareholders
 
Item 1: Approval of financial statements for the 45th business year
(1/1/2012 ~ 12/31/2012)
 
1. Consolidated financial Statements
 
(1) Consolidated Statements of Financial Position
(Unit: Million Won)

 
2012
2011
. Current assets
54,847,586
48,926,350
1. Cash and cash equivalents
6,759,338
6,231,946
2. Short-term financial instruments
12,384,057
9,182,575
3. Trade notes and accounts receivable
3,686,824
3,845,517
4. Other receivables
2,304,410
2,240,482
5. Other financial assets
109,299
356,444
6. Inventories
6,772,864
6,237,752
7. Other assets
1,905,445
1,137,862
8. Current tax assets
34,575
36,084
9. Financial services receivables
20,867,467
19,657,688
10. Non-current assets held for sale
23,307
-
. Non-current assets
66,690,228
60,553,625
1. Long-term financial instruments
1,359
211,540
2. Long-term trade notes and accounts receivable
43,801
76,843
3. Other receivables
1,036,609
987,207
4. Other financial assets
1,594,464
1,897,943
5. Other assets
44,424
1,288
6. Property, plant and equipment
20,739,858
19,548,048
7. Investment property
282,832
282,427
8. Intangibles
2,883,218
2,660,109
9. Investments in joint ventures and associates
13,117,731
11,709,238
10. Deferred tax liabilities
489,080
458,287
11. Financial services receivables
18,626,764
17,452,441
12. Operating lease assets
7,830,088
5,268,254
Total assets
121,537,814
109,479,975
. Current liabilities
32,835,699
33,163,508
1. Trade notes and accounts payable
6,841,326
6,666,406
2. Other payables
4,542,007
3,752,684
3. Short-term borrowings
6,781,749
7,880,014
4. Current portion of long-term debt & debentures
7,912,341
8,320,194
5. Income tax payables
550,847
925,519
6. Provisions
1,768,014
1,686,161
7. Other financial liabilities
148,311
455,914
8. Other liabilities
4,291,104
3,476,616
. Non-current liabilities
40,784,540
35,988,765
1. Long-term other payables
8,271
29,471
2. Debentures
26,370,689
23,654,325
3. Long-term debt
4,142,473
3,484,127
4. Defined benefit obligations
821,749
648,639
5. Provisions
5,240,744
4,960,992
6. Other financial liabilities
356,193
200,197
7. Other liabilities
1,482,358
1,537,003
8. Deferred tax liabilities
2,362,063
1,474,011
Total liabilities
73,620,239
69,152,273
. Equity attributable to the owners of the Parent Company
44,039,059
37,113,033
1. Capital stock
1,488,993
1,488,993
2. Capital surplus
4,158,988
4,114,010
3. Other capital items
(1,128,779)
(1,128,779)
4. Accumulated other comprehensive income
(473,373)
375,281
5. Retained earnings
39,993,230
32,263,528
. Non-controlling interests
3,878,516
3,214,669
Total shareholders’ equity
47,917,575
40,327,702
Total liabilities & shareholders’ equity
121,537,814
109,479,975
 
(2) Consolidated Statements of Income (Statement of Comprehensive Income)
- Consolidated Statements of Income
(Unit: Million Won)
 
2012
2011
. Sales
84,469,721
77,797,895
. Cost of Sales
64,972,145
58,902,023
. Gross profit
19,497,576
18,895,872
. Selling and administrative expenses
11,060,629
10,867,043
. Operating Income
8,436,947
8,028,829
1. Gain on investment in JV and associates, net
2,579,906
2,403,753
2. Finance Income
969,726
747,546
3. Finance Expenses
624,473
779,666
4. Other Income
1,231,360
1,030,593
5. Other Expenses
988,336
983,945
. Income before income tax
11,605,130
10,447,110
1. Income tax expense
2,548,853
2,342,247
. Profit for the period
9,056,277
8,104,863
1. Profit attributable to owners of the Parent Company
8,561,825
7,655,871
2. Non-controlling interests
494,452
448,992
. Earnings per share
 
 
1. Basic earnings per share
KRW 31,515
KRW 28,200
2. Diluted earnings per share
KRW 31,515
KRW 28,200
 
- Consolidated Statements of Comprehensive Income
(Unit: Million Won)
 
2012
2011
. Profit for the period
9,056,277
8,104,863
II. Other comprehensive income (expenses)
(1,202,730)
(251,659)
1. Gain(loss) on valuation of available-for-sale financial assets, net
(80,693)
(91,860)
2. Gain(loss) on valuation of cash flow hedge derivatives, net
55,471
4,004
3. Changes in valuation of equity-accounted investees, net
(293,487)
158,977
4. Actuarial loss on defined benefit obligations, net
(247,197)
(175,500)
5. Gain(loss) on foreign operations translation, net
(636,824)
(147,280)
III. Total comprehensive income
7,853,547
7,853,204
1. Comprehensive income attributable to owners of the Parent Company
7,378,454
7,415,551
2. Non-controlling interests
475,093
437,653
 
(3) Consolidated Statements of Changes in shareholders’ Equity
(Unit: Million Won)
 
Income attributable to owners of the Parent Company
Non-controlling interests
Total equity
Capital stock
Capital surplus
Other capital items
Accumulated other comprehensive income
Retained earning
Total
Balance at January 1, 2011
1,488,993
3,900,935
(918,214)
409,914
25,216,163
30,097,791
2,790,182
32,887,973
Comprehensive income
 
 
 
 
 
 
 
 
Profit for the period
 
 
 
 
7,655,871
7,655,871
448,992
8,104,863
Gain(loss) on valuation of available-for-sale financial assets, net
 
 
 
(91,493)
 
(91,493)
(367)
(91,860)
Gain(loss) on valuation of cash flow hedge derivatives, net
 
 
 
2,891
 
2,891
1,113
4,004
Changes in valuation of equity-accounted investees, net
 
 
 
199,216
(40,249)
158,967
10
158,977
Actuarial loss on defined benefit obligations, net
 
 
 
 
(165,438)
(165,438)
(10,062)
(175,500)
Loss on foreign operations translation, net
 
 
 
(145,247)
 
(145,247)
(2,033)
(147,280)
Total comprehensive income
 
 
 
(34,633)
7,450,184
7,415,551
437,653
7,853,204
Transactions with owners, recorded directly in equity
 
 
 
 
 
 
 
 
Payment of cash dividends
 
 
 
 
(412,227)
(412,227)
(45,423)
(457,650)
Purchase of treasury stock
 
 
(400,137)
 
 
(400,137)
 
(400,137)
Disposal of treasury stock
 
194,959
189,572
 
 
384,531
 
384,531
Increase in subsidiaries’ capital-stock
 
 
 
 
 
 
12,871
12,871
Disposal of subsidiaries stock
 
18,116
 
 
 
18,116
 
18,116
Other
 
 
 
 
9,408
9,408
19,386
28,794
Total transactions with owners, recorded directly in equity
 
213,075
(210,565)
 
(402,819)
(400,309)
(13,166)
(413,475)
Balance at December 31, 2011
1,488,993
4,114,010
(1,128,779)
375,281
32,263,528
37,113,033
3,214,669
40,327,702
Balance at January 1, 2012
1,488,993
4,114,010
(1,128,779)
375,281
32,263,528
37,113,033
3,214,669
40,327,702
Comprehensive income
 
 
 
 
 
 
 
 
Profit for the period
 
 
 
 
8,561,825
8,561,825
494,452
9,056,277
Gain(loss) on valuation of available-for-sale financial assets, net
 
 
 
(81,330)
 
(81,330)
637
(80,693)
Gain(loss) on valuation of cash flow hedge derivatives, net
 
 
 
29,746
 
29,746
25,725
55,471
Changes in valuation of equity-accounted investees, net
 
 
 
(189,602)
(102,759)
(292,361)
(1,126)
(293,487)
Actuarial loss on defined benefit obligations, net
 
 
 
 
(231,958)
(231,958)
(15,239)
(247,197)
Loss on foreign operations translation, net
 
 
 
(607,468)
 
(607,468)
(29,356)
(636,824)
Comprehensive income
 
 
 
(848,654)
8,227,108
7,378,454
475,093
7,853,547
Transactions with owners, recorded directly in equity
 
 
 
 
 
 
 
 
Payment of cash dividends
 
 
 
 
(480,105)
(480,105)
(43,262)
(523,367)
Increase in subsidiaries’ capital-stock
 
42,866
 
 
 
42,866
232,050
274,916
Disposal of subsidiaries stock
 
2,112
 
 
 
2,112
(10)
2,102
Other
 
 
 
 
(17,301)
(17,301)
(24)
(17,325)
Total transactions with owners, recorded directly in equity
 
44,978
 
 
(497,406)
(452,428)
188,754
(263,674)
Balance at December 31, 2012
1,488,993
4,158,988
(1,128,779)
(473,373)
39,993,230
44,039,059
3,878,516
47,917,575
 
 
 
 
(4) Consolidated Statements of Cash Flows
(Unit: Million Won)
 
2012
2011
. Cash flows from operating activities
5,339,686
4,132,119
1.Cash generated from operations
7,868,089
6,426,813
(1) Profit for the period
9,056,277
8,104,863
(2) Adjustments
7,123,391
6,918,040
(3) Changes in operating assets and liabilities
(8,311,579)
(8,596,090)
2.Interest received
617,736
550,026
3.Interest paid
(1,660,401)
(1,722,736)
4.Dividend received
744,132
605,273
5.Income tax paid
(2,229,870)
(1,727,257)
. Cash flows from investing activities
(7,199,133)
(7,116,095)
Net increase(decrease) in short-term financial instruments
(1,900,099)
(337,862)
Proceeds from disposal of other financial assets
448,109
764,699
Proceeds from disposal of other receivables
93,261
412,462
Proceeds from withdrawal of long-term financial instruments
-
5
Proceeds from disposal of property, plant and equipment
69,230
108,727
Proceeds from disposal of intangible assets
1,935
11,047
Proceeds from disposal of investments in joint ventures and associates
241,806
355,584
Acquisition of other financial assets
(539,551)
(764,965)
Acquisition of other receivables
(97,098)
(394,144)
Purchase of long-term financial instruments
(1,160,000)
(500,000)
Acquisition of property, plant and equipment
(3,000,038)
(2,899,177)
Acquisition of intangible assets
(798,607)
(763,234)
Acquisition of investments in subsidiaries
(290,989)
-
Acquisition of investments in joint ventures and associates
(275,104)
(3,105,180)
Other cash payments from investing activities
8,012
(4,057)
.Cash flows from financing activities
2,572,831
3,108,804
Net increase (decrease) in short-term borrowings
(1,363,213)
(1,084,499)
Proceeds from issue of debentures and long-term debt
23,448,538
15,501,739
Paid in capital increase of subsidiaries
277,476
10,618
Repayment of current portion of long-term debt and debentures
(18,890,467)
(10,436,527)
Repayment of other financial liabilities
(341,484)
-
Purchase of treasury stock
-
(400,137)
Dividends paid
(523,367)
(457,650)
Other cash payments from financing activities
(34,652)
(24,740)
. Effect of exchange rate changes on cash and cash equivalents
(185,992)
(108,697)
. Net increase in cash and cash equivalents
527,392
16,131
. Cash and cash equivalents, beginning of the period
6,231,946
6,215,815
. Cash and cash equivalents, end of the period
6,759,338
6,231,946
 
 
 
 
 
 
 
2. Separate financial Statements
 
(1) Separate Statements of Financial Position
(Unit: Million Won)

 
2012
2011
. Current assets
19,653,944
17,249,883
1. Cash and cash equivalents
1,395,068
1,510,820
2. Short-term financial instruments
11,658,545
8,547,166
3. Trade notes and accounts receivable
3,982,708
4,469,652
4. Other receivables
516,398
637,723
5. Other financial assets
77,705
29,574
6. Inventories
1,696,775
1,832,025
7. Other assets
326,745
222,923
. Non-current assets
34,291,985
32,986,127
1. Long-term financial instruments
32
210,032
2. Long-term trade notes and accounts receivable
14,140
29,013
3. Other receivables
901,180
875,654
4. Other financial assets
1,465,314
1,567,355
5. Property, plant and equipment
13,306,218
12,524,580
6. Investment property
203,209
208,905
7. Intangibles
2,036,219
2,074,929
8. Investments in subsidiaries, joint ventures and associates
16,365,673
15,495,659
Total assets
53,945,929
50,236,010
. Current liabilities
11,153,049
11,919,397
1. Trade notes and accounts payable
3,870,150
3,947,963
2. Other payables
2,477,901
2,034,199
3. Short-term borrowings
2,103,458
2,632,334
4. Current portion of long-term debt & debentures
202,343
401,960
5. Income tax payables
365,517
757,295
6. Provisions
1,172,022
1,226,774
7. Other financial liabilities
5,137
29,483
8. Other liabilities
956,521
889,389
. Non-current liabilities
5,773,224
5,794,979
1. Debentures
698,172
897,193
2. Lont-term debt
11,561
13,904
3. Defined benefit obligations
639,167
459,161
4. Provisions
4,258,748
4,320,837
5. Other financial liabilities
8,436
10,981
6. Other liabilities
51,549
43,808
7. Deferred tax liabilities
105,591
49,095
Total liabilities
16,926,273
17,714,376
1. Capital stock
1,488,993
1,488,993
2. Capital surplus
3,964,962
3,964,962
3. Other capital items
(1,128,779)
(1,128,779)
4. Accumulated other comprehensive income
675,591
758,981
5. Retained earnings
32,018,889
27,437,477
Total shareholders’ equity
37,019,656
32,521,634
Total liabilities & shareholders’ equity
53,945,929
50,236,010
 
(2) Separate Statements of Income (Separate Statement of Comprehensive Income)
- Separate Statements of Income
(Unit: Million Won)
 
2012
2011
. Sales
43,162,401
42,774,077
. Cost of Sales
32,810,120
31,945,571
. Gross profit
10,352,281
10,828,506
. Selling and administrative expenses
6,055,053
6,144,093
. Operating Income
4,297,228
4,684,413
1. Gain on investment in joint ventures and associates, net
175,706
186,835
2. Finance Income
1,979,435
1,267,346
3. Finance Expenses
239,182
362,302
4. Other Income
628,418
569,190
5. Other Expenses
463,173
476,485
. Income before income tax
6,378,432
5,868,997
1. Income tax expense
1,104,984
1,128,111
. Profit for the period
5,273,448
4,740,886
. Earnings per share
 
 
1. Basic earnings per share
KRW 19,404
KRW 17,456
2. Diluted earnings per share
KRW 19,404
KRW 17,456
 
- Separate Statements of Comprehensive Income
(Unit: Million Won)
 
2012
2011
. Profit for the period
5,273,448
4,740,886
II. Other comprehensive income (expenses)
(295,321)
(223,753)
1.Gain(loss) on valuation of available-for-sale financial assets, net
(82,160)
(91,019)
2.Gain(loss) on valuation of cash flow hedge derivatives, net
(1,230)
(3,446)
3.Actuarial loss on defined benefit obligations, net
(211,931)
(129,288)
III.Total comprehensive income
4,978,127
4,517,133
 
 
(3) Separate Statements of Changes in shareholders’ Equity
(Unit: Million Won)
 
Capital stock
Capital surplus
Other capital items
Accumulated other comprehensive income
Retained earning
Total
Balance at January 1, 2011
1,488,993
3,770,003
(918,214)
853,446
23,238,106
28,432,334
Payment of cash dividends
 
 
 
 
(412,227)
(412,227)
Purchase of treasury stock
 
 
(400,137)
 
 
(400,137)
Disposal of treasury stock
 
194,959
189,572
 
 
384,531
Gain(loss) on valuation of available-for-sale financial assets, net
 
 
 
(91,019)
 
(91,019)
Gain on valuation of cash flow hedge derivatives, net
 
 
 
(3,446)
 
(3,446)
Actuarial loss on defined benefit obligations, net
 
 
 
 
(129,288)
(129,288)
Profit for the period
 
 
 
 
4,740,886
4,740,886
Balance at December 31, 2011
1,488,993
3,964,962
(1,128,779)
758,981
27,437,477
32,521,634
Balance at January 1, 2012
1,488,993
3,964,962
(1,128,779)
758,981
27,437,477
32,521,634
Payment of cash dividends
 
 
 
 
(480,105)
(480,105)
Gain(loss) on valuation of available-for-sale financial assets, net
 
 
 
(82,160)
 
(82,160)
Gain on valuation of cash flow hedge derivatives, net
 
 
 
(1,230)
 
(1,230)
Actuarial loss on defined benefit obligations, net
 
 
 
 
(211,931)
(211,931)
Profit for the period
 
 
 
 
5,273,448
5,273,448
Balance at December 31, 2012
1,488,993
3,964,962
(1,128,779)
675,591
32,018,889
37,019,656
 
 
 
 
(4) Separate Statements of Cash Flows
(Unit: Million Won)
 
2012
2011
. Cash flows from operating activities
7,140,705
6,470,652
1.Cash generated from operations
6,809,016
6,558,006
(1) Profit for the period
5,273,448
4,740,886
(2) Adjustments
1,635,580
2,963,469
(3) Changes in operating assets and liabilities
(100,012)
(1,146,349)
2.Interest received
386,851
338,961
3.Interest paid
(75,922)
(145,608)
4.Dividend received
1,366,742
793,343
5.Income tax paid
(1,345,982)
(1,074,050)
. Cash flows from investing activities
(5,866,345)
(6,189,314)
Net increase(decrease) in short-term financial instruments
(1,741,379)
(219,353)
Proceeds from disposal of other financial assets
22,710
4,152
Proceeds from disposal of other receivables
60,870
364,904
Proceeds from withdrawal of long-term financial instruments
-
5
Proceeds from disposal of property, plant and equipment
19,829
22,008
Proceeds from disposal of intangible assets
41
5,620
Proceeds from disposal of subsidiaries, investments in joint ventures and associates
241,806
139,471
Acquisition of other financial assets
(19,926)
(37,087)
Acquisition of other receivables
(69,304)
(380,635)
Purchase of long-term financial instruments
(1,160,000)
(500,000)
Acquisition of property, plant and equipment
(1,657,256)
(1,425,340)
Acquisition of intangible assets
(631,529)
(625,526)
Acquisition of investments in subsidiaries, joint ventures and associates
(932,207)
(3,537,533)
.Cash flows from financing activities
(1,390,112)
(543,355)
Net increase (decrease) in short-term borrowings
(508,047)
621,751
Proceeds from issue of debentures
-
298,697
Repayment of current portion of long-term debt and debentures
(401,960)
(651,439)
Purchase of treasury stock
-
(400,137)
Dividends paid
(480,105)
(412,227)
. Net increase in cash and cash equivalents
(115,752)
(262,017)
. Cash and cash equivalents, beginning of the period
1,510,820
1,772,837
. Cash and cash equivalents, end of the period
1,395,068
1,510,820
 
 
(5) Separate Statements of Appropriations of Retained Earnings
 
(Unit: Million Won)
 
2012
2011
. Unappropriated retained earnings
5,064,118
8,015,717
1.Beginning of year
2,601
3,404,119
2. Actuarial loss, net
(211,931)
(129,288)
3. Net income
5,273,448
4,740,886
II. Appropriation of retained earnings
5,062,916
8,013,116
1.Legal reserve
52,083
48,011
2.Reserve for research development
2,140,000
3,530,000
3.Reserve for technology development
2,350,000
3,955,000
4.Cash Dividends
520,833
480,105
(Details of cash dividends amount and rate )
FY 45th: Common shares KRW 1,900 (38%)
Series 1 preferred shares KRW 1,950 (39%)
Series 2 preferred shares KRW 2,000 (40%)
Series 3 preferred shares KRW 1,950 (39%)
 
FY 44rd: Common shares KRW 1,750 (35%)
Series 1 preferred shares KRW 1,800 (36%)
Series 2 preferred shares KRW 1,850 (37%)
Series 3 preferred shares KRW 1,800(36%)
 
 
 
III.Unappropriated retained earnings, end of year
1,202
2,601
 
 
 
 
 
Item 2: Appointment of Director(s)
 
*Nominees (4 persons)

Name
Date of birth
Major Career
Transaction with the Company
Relationship with
Major Shareholder
Recommended by
Chung,
Eui Sun
1970. Oct. 18
·;Vice Chairman of Hyundai Motor Company (current)
·;President of Kia Motor Company (former)
None
Director
BOD1
Kim,
Choong Ho
1951. Oct. 13
·;President & CEO of Hyundai Motor Company (current)
·;Head of Korea Domestic Business Divisionof Hyundai Motor Company (former)
None
Director of an affiliated company
BOD1
Nam,
Sung Il
1954. Apr. 18
·;Professor of Economics, Sogang University (current)
·;Dean, Graduate School of Economics, Sogang University (former)
None
Director of an affiliated company
EDCRC2
Yi,
You Jae
1960. Jul. 15
·;Professor of Business Administration, Seoul National University (current)
·;President of the Korean Marketing Association (former)
None
Director of an affiliated company
EDCRC2
1. Board of Directors
2. External Director Candidate Recommendation Committee
 
 
 
 
Item 3: Appointment of member(s) of Audit Committee
 
*Nominees (1 person)

Name
Date of birth
Major Career
Transaction with the Company
Relationship with
Major Shareholder
Recommended by
Nam,
Sung-Il
1954. Apr. 18
·;Professor of Economics, Sogang University (current)
·;Dean, Graduate School of Economics, Sogang University (former)
None
Director of an affiliated company
BOD1
1. Board of Directors

Item 4: Amendment to the Articles of Incorporation
 

Article
Before Amendment
After Amendment
Purpose of Amendment
Business Purpose
(Article 2)
(20) To set up gas facilities (fourth-class)
(20) To set up gas facilities
Revised Korean
Commercial Code (Revision of Article)
(newly established)
(30) Manufacture of Other Basic Iron and Steel
R&D activities for the purpose of the development of materials for auto parts.
(30) Any and all businesses which are incidental to any of the foregoing objectives.
(31) Any and all businesses which are incidental to any of the foregoing objectives.
 
Addendum
(2013.3.15)
(newly established)
Article 1. (Effective Date)
 
This Amended Articles of Incorporation shall be effective on and after the resolution passed at the 45th Annual General Meeting.
 
 
 
 
 
Item 5: Approval of Compensation Cap for Directors
 

Year
Number of BOD
Compensation Cap
2013
9 persons
15 billion Korean Won
 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAEAPAAAASDEEF
Date   Source Headline
2nd May 20248:18 amRNSApril 2024 Sales Results
25th Apr 20248:07 amRNSResolution of Quarterly Dividend
25th Apr 20248:04 amRNSQ1 2024 Business Results
2nd Apr 20247:00 amRNSMarch 2024 Sales Results
21st Mar 20244:31 pmRNSRetirement of Shares
21st Mar 20244:25 pmRNSResult of the 56th Annual General Meeting
4th Mar 20248:59 amRNSFebruary 2024 Sales Results
20th Feb 20247:00 amRNSConvening Notice of Annual General Meeting
14th Feb 20247:00 amRNSJanuary 2024 Sales Results
25th Jan 20249:12 amRNSResolution of Year-end Dividend
25th Jan 20249:11 amRNSNotice of Record Date for Year-end Dividend
25th Jan 20249:06 amRNSQ4 2023 Business Results
3rd Jan 20248:20 amRNS2024 Business Plan
3rd Jan 20248:19 amRNSDecember 2023 Sales Results
15th Dec 20237:00 amRNSNotice of Record Date for Dividend
4th Dec 20237:00 amRNSNovember 2023 Sales Results
2nd Nov 20237:00 amRNSOctober 2023 Sales Results
27th Oct 20237:00 amRNSResolution of Quarterly Dividend
27th Oct 20237:00 amRNSQ3 2023 Business Results
4th Oct 20238:25 amRNSSeptember 2023 Sales Results
18th Sep 20237:00 amRNSNotice of Record Date for Quarterly Dividend
1st Sep 20238:34 amRNSAugust 2023 Sales Results
2nd Aug 20237:00 amRNSJuly 2023 Sales Results
26th Jul 20239:15 amRNSResolution of Interim Dividend
26th Jul 20239:14 amRNSQ2 2023 Business Results
3rd Jul 20237:57 amRNSJune 2023 Sales Results
16th Jun 20237:00 amRNSNotice of Record Date for Interim Dividend
1st Jun 20239:21 amRNSMay 2023 Sales Results
4th May 20237:00 amRNSApril 2023 Sales Results
25th Apr 20238:17 amRNSQ1 2023 Business Results
3rd Apr 20238:23 amRNSMarch 2023 Sales Results
24th Mar 20237:00 amRNSResult of Annual General Meeting
3rd Mar 20237:22 amRNSConvening Notice of Annual General Meeting
3rd Mar 20237:00 amRNSFebruary 2023 Sales Results
2nd Feb 20237:00 amRNSResolution of Year-end dividend
2nd Feb 20237:00 amRNSJanuary 2023 Sales Results
2nd Feb 20237:00 amRNSQ4 2022 Business Results
2nd Feb 20237:00 amRNSRetirement of Shares
3rd Jan 20237:25 amRNSDecember 2022 Sales Results
3rd Jan 20237:23 amRNS2023 Business Plan
12th Dec 20227:00 amRNSNotice of Record Date for Year-end Dividend
1st Dec 20227:00 amRNSNovember 2022 Sales Results
1st Nov 20227:47 amRNSOctober 2022 Sales Results
24th Oct 20227:47 amRNSGuidance Update for 2022
24th Oct 20227:44 amRNSQ3 2022 Business Results
4th Oct 20228:45 amRNSSeptember 2022 Sales Results
1st Sep 20227:44 amRNSAugust 2022 Sales Results
1st Aug 20227:57 amRNSJuly 2022 Sales Results
21st Jul 20227:00 amRNSResolution of Interim Dividend
21st Jul 20227:00 amRNSQ2 2022 Business Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.